Cargando…
Inhibition of the MID1 protein complex: a novel approach targeting APP protein synthesis
Alzheimer’s disease (AD) is characterized by two neuropathological hallmarks: senile plaques, which are composed of amyloid-β (Aβ) peptides, and neurofibrillary tangles, which are composed of hyperphosphorylated tau protein. Aβ peptides are derived from sequential proteolytic cleavage of the amyloid...
Autores principales: | Matthes, Frank, Hettich, Moritz M., Schilling, Judith, Flores-Dominguez, Diana, Blank, Nelli, Wiglenda, Thomas, Buntru, Alexander, Wolf, Hanna, Weber, Stephanie, Vorberg, Ina, Dagane, Alina, Dittmar, Gunnar, Wanker, Erich, Ehninger, Dan, Krauss, Sybille |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841321/ https://www.ncbi.nlm.nih.gov/pubmed/29531801 http://dx.doi.org/10.1038/s41420-017-0003-8 |
Ejemplares similares
-
The Anti-Diabetic Drug Metformin Reduces BACE1 Protein Level by Interfering with the MID1 Complex
por: Hettich, Moritz M., et al.
Publicado: (2014) -
Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex
por: Schweiger, Susann, et al.
Publicado: (2017) -
Prions Ex Vivo: What Cell Culture Models Tell Us about Infectious Proteins
por: Krauss, Sybille, et al.
Publicado: (2013) -
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
por: Unterbruner, Kristoffer, et al.
Publicado: (2018) -
The MID1 Protein: A Promising Therapeutic Target in Huntington’s Disease
por: Heinz, Annika, et al.
Publicado: (2021)